White & Case in the acquisition of Intercept Pharmaceuticals

White & Case has advised Advanz Pharma – a specialty pharmaceutical company headquartered in London – on its acquisition of the ex-US business of Intercept Pharmaceuticals, the biopharmaceutical company. 

The transaction is actively supported by Advanz Pharma’s owner Nordic Capital, a leading private equity investor with extensive experience and expertise in the global healthcare market, which acquired Advanz Pharma in June 2021.

The White & Case team that advised on the transaction was led by an international team led by Mike Weir (London) and Andres Liivak that involved in Madrid Laura del Olmo and Gracia Truan.